award

A Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer

  • Award Number: R21CA259808

  • ORGANIZATION: NATIONAL CANCER INSTITUTE

  • OPDIV: NIH

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 05/19/2021

  • PERIOD OF PERFORMANCE END DATE: 04/30/2024